Riskpilot← Back to searchSign inGet full access32 leenden AB
ABActiveOrg 5592065543NorrköpingDental practice care activities · NACE 8623Est. 201910-19 employees
Revenue 2024
SEK 8,7M
+4% vs 2023
EBITDA margin
6.1%
-10% vs 2023
Equity ratio
45.2%
Financial strength
Net profit 2024
SEK 331K
-20% vs 2023
| Revenue | SEK 8,7M | +4% |
| EBITDA | SEK 525K | -10% |
| Net profit | SEK 331K | -20% |
| Total assets | SEK 1,9M | -32% |
| Equity | SEK 842K | -17% |
| Employees | — | — |
Legal name
32 leenden AB
Org number
5592065543
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
22 maj 2019
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Bolaget skall bedriva tandläkarmottagning samt därmed förenlig verksamhet.
Address
Norrköping
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 641 | 3 778 | 7 191 | 8 347 | 8 661 |
| Staff expenses | — | — | −3 254 | −4 213 | −4 482 |
| EBITDA | −992 | −654 | 979 | 581 | 525 |
| Depreciation & amort. | −12 | −52 | −76 | −193 | −208 |
| EBIT | −1 004 | −706 | 903 | 388 | 317 |
| Net financials | — | — | 3 | 27 | 19 |
| Profit before tax | −1 004 | −706 | 906 | 415 | 337 |
| Tax | −0 | −0 | — | — | −5 |
| Net profit | −1 004 | −706 | 906 | 415 | 331 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 491 | 952 | 2 645 | 2 758 | 1 864 |
| Equity | 146 | 90 | 996 | 1 011 | 842 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 345 | 862 | 1 649 | 1 747 | 1 022 |
| Total debt | 1 345 | 862 | 1 649 | 1 747 | 1 022 |
EBITDA margin
6.1%
This company
15.8%
Market median
-61% vs market
20202024
Equity ratio
45.2%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
39.3%
This company
18.4%
Market median
+114% vs market
20202024
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
20202024
Asset turnover
4.65×
This company
1.12×
Market median
+315% vs market
20202024
Debt / equity
1.21×
This company
0.62×
Market median
-95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PA | Audit | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of 32 leenden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pierre Alexander Polhammar | Audit | 0 companies |
| Kais Abdulhussein Mahod | Board of Directors | 0 companies |
| Eva Adamo | Chairman | 0 companies |
| Sinan Findikly | Board of Directors | 0 companies |
| Fadi Kawmi | Deputy Board Member | 0 companies |